Narrow search
Showing 1 - 10 of 4,075
Cover Image
Bridging the Gap: Improving Clinical Development and the Regulatory Pathways for Health Products for Neglected Diseases
Bollyky, Thomas J. - 2010
. These include drugs, vaccines, and diagnostics for malaria and tuberculosis, which kill millions of people annually, plus …
Persistent link: https://www.econbiz.de/10008466386
Cover Image
Farmers’ willingness to vaccinate against endemic animal diseases: A theoretical approach
Rault, Arnaud; Krebs, Stephane - European Association of Agricultural Economists - EAAE - 2014
The aim of this paper is to propose an analytical framework to explore farmers’ vaccination decisions against endemic … farmer’s vaccination decisions over time and the resulting disease dynamics. Numerical simulations are then performed to …
Persistent link: https://www.econbiz.de/10011125073
Cover Image
Impact of Disasters and Disaster Risk Management in Singapore: A Case Study of Singapore's Experience in Fighting the SARS Epidemic
LAI, Allen Yu-Hung; Tan, Seck L. - Economic Research Institute for ASEAN and East Asia (ERIA) - 2013
most significant disasters is the Severe Acute Respiratory Syndrome (SARS) epidemic in 2003. The SARS outbreak was … SARS epidemic. We draw on the lesson-learning from Singapore’s experience in fighting the SARS epidemic, and discuss … and the extent it was utilized. This helps to explain the success level of the containment of the SARS epidemic. …
Persistent link: https://www.econbiz.de/10010925550
Cover Image
Analysis of the success rates of new drug development in Japan and the lag behind the US
Hirai, Yuka; Yamanaka, Yosuke; Kusama, Makiko; … - In: Health Policy 104 (2012) 3, pp. 241-246
The launch delay of new drugs has been a major public concern in Japan. Although it is recognized that the delay results from industrial R&D behaviors and regulatory conditions in the global market, the specific mechanisms underlying the significant delay have been unexplained. This study...
Persistent link: https://www.econbiz.de/10010573194
Cover Image
Advancing Cervical Cancer Prevention in India
Krishnan, S.; Madsen, E.; Porterfield, D.; Varghese, B.; … - Economics Research, World Bank Group - 2015
In 2010, nearly 74,000 new cases of cervical cancer were diagnosed among Indian women. This number is estimated to increase to as high as 225,000 cases by 2025. Cervical cancer is also the leading cause of cancer deaths in India, as most cases are not detected until they are in an advanced...
Persistent link: https://www.econbiz.de/10011261539
Cover Image
Advancing Cervical Cancer Prevention in India: Insights from Research and Programs
Krishnan, Suneeta; Madsen, Emily; Porterfield, Deborah; … - Economics Research, World Bank Group
further investigation. Although primary prevention through HPV vaccination has been endorsed by WHO, under certain conditions …
Persistent link: https://www.econbiz.de/10010754597
Cover Image
Achieving MDGs 4&5: Bolivia's Progress on Maternal and Child Health
Cortez, Rafael; Lavadenz, Fernando; Saadat, Seemeen; … - Economics Research, World Bank Group - 2014
Bolivia is a lower-middle income country, but one of the poorest in South America, with a per capita GNI of US$ 5,750 in 2013 and an average GNI growth rate of 4.4 percent during the last ten years. Nearly 36 percent of its population of 10.6 million (2013) are aged 0 to 14 years and one third...
Persistent link: https://www.econbiz.de/10011161362
Cover Image
Peering into the pharmaceutical “pipeline”: Investigational drugs, clinical trials, and industry priorities
Fisher, Jill A.; Cottingham, Marci D.; Kalbaugh, Corey A. - In: Social Science & Medicine 131 (2015) C, pp. 322-330
existing case studies detailing the expanding – and often problematic – role of pharmaceuticals in society. To access the …
Persistent link: https://www.econbiz.de/10011263481
Cover Image
Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness
Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; … - Suntory and Toyota International Centres for Economics … - 2005
To overcome the problem of insufficient research and development (R&D) on vaccines for diseases concentrated in low …-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit …
Persistent link: https://www.econbiz.de/10005150969
Cover Image
Vaccine Supply: Effects of Regulation and Competition
Danzon, Patricia; Pereira, Nuno Sousa - In: International Journal of the Economics of Business 18 (2011) 2, pp. 239-271
In US vaccine markets, competing producers with high fixed, sunk costs face relatively concentrated demand. The resulting price and quality competition leads to the exit of all but one or very few producers per vaccine. Our empirical analysis of exits from US vaccine markets supports the...
Persistent link: https://www.econbiz.de/10009276800